Cargando…

Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour

OBJECTIVE: To investigate salivary cortisol samples in patients with Parkinson's disease (PD) with and without impulsive compulsive behaviours (ICB) during a risk task. METHODS: Salivary cortisol levels were measured in 13 PD patients without ICB (PD−ICB) and in 15 PD patients with ICB (PD+ICB)...

Descripción completa

Detalles Bibliográficos
Autores principales: Djamshidian, Atbin, O'Sullivan, Sean S, Papadopoulos, Andrew, Bassett, Paul, Shaw, Karen, Averbeck, Bruno B, Lees, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171980/
https://www.ncbi.nlm.nih.gov/pubmed/21478206
http://dx.doi.org/10.1136/jnnp.2011.245746
_version_ 1782211811450290176
author Djamshidian, Atbin
O'Sullivan, Sean S
Papadopoulos, Andrew
Bassett, Paul
Shaw, Karen
Averbeck, Bruno B
Lees, Andrew
author_facet Djamshidian, Atbin
O'Sullivan, Sean S
Papadopoulos, Andrew
Bassett, Paul
Shaw, Karen
Averbeck, Bruno B
Lees, Andrew
author_sort Djamshidian, Atbin
collection PubMed
description OBJECTIVE: To investigate salivary cortisol samples in patients with Parkinson's disease (PD) with and without impulsive compulsive behaviours (ICB) during a risk task. METHODS: Salivary cortisol levels were measured in 13 PD patients without ICB (PD−ICB) and in 15 PD patients with ICB (PD+ICB) before, after medication and throughout the day, and were compared with results with 14 healthy controls. All participants also performed a gambling task to assess risk taking behaviour. RESULTS: Significantly higher diurnal cortisol levels were found in the PD−ICB group compared with healthy controls but no differences were seen between the PD+ICB and the control group. Increased cortisol levels were significantly correlated with increased risk taking in PD+ICB patients but no interaction was found in the PD−ICB group. CONCLUSIONS: The findings are in keeping with previous studies which have linked low cortisol levels with antisocial behaviour. The higher cortisol levels during the risk task in the PD+ICB group are consistent with reports in pathological gamblers during gambling and addicts during drug abuse. The results support the hypothesis that cortisol plays an important role in risk taking in ICBs.
format Online
Article
Text
id pubmed-3171980
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-31719802011-09-23 Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour Djamshidian, Atbin O'Sullivan, Sean S Papadopoulos, Andrew Bassett, Paul Shaw, Karen Averbeck, Bruno B Lees, Andrew J Neurol Neurosurg Psychiatry Research Paper OBJECTIVE: To investigate salivary cortisol samples in patients with Parkinson's disease (PD) with and without impulsive compulsive behaviours (ICB) during a risk task. METHODS: Salivary cortisol levels were measured in 13 PD patients without ICB (PD−ICB) and in 15 PD patients with ICB (PD+ICB) before, after medication and throughout the day, and were compared with results with 14 healthy controls. All participants also performed a gambling task to assess risk taking behaviour. RESULTS: Significantly higher diurnal cortisol levels were found in the PD−ICB group compared with healthy controls but no differences were seen between the PD+ICB and the control group. Increased cortisol levels were significantly correlated with increased risk taking in PD+ICB patients but no interaction was found in the PD−ICB group. CONCLUSIONS: The findings are in keeping with previous studies which have linked low cortisol levels with antisocial behaviour. The higher cortisol levels during the risk task in the PD+ICB group are consistent with reports in pathological gamblers during gambling and addicts during drug abuse. The results support the hypothesis that cortisol plays an important role in risk taking in ICBs. BMJ Group 2011-04-08 2011-10 /pmc/articles/PMC3171980/ /pubmed/21478206 http://dx.doi.org/10.1136/jnnp.2011.245746 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle Research Paper
Djamshidian, Atbin
O'Sullivan, Sean S
Papadopoulos, Andrew
Bassett, Paul
Shaw, Karen
Averbeck, Bruno B
Lees, Andrew
Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
title Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
title_full Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
title_fullStr Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
title_full_unstemmed Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
title_short Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour
title_sort salivary cortisol levels in parkinson's disease and its correlation to risk behaviour
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171980/
https://www.ncbi.nlm.nih.gov/pubmed/21478206
http://dx.doi.org/10.1136/jnnp.2011.245746
work_keys_str_mv AT djamshidianatbin salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour
AT osullivanseans salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour
AT papadopoulosandrew salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour
AT bassettpaul salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour
AT shawkaren salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour
AT averbeckbrunob salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour
AT leesandrew salivarycortisollevelsinparkinsonsdiseaseanditscorrelationtoriskbehaviour